Digital Therapeutics Podcast

If you’ve been keeping up with the news you’ll know that since March this year, Kranus Edera has been permanently listed as a digital health application by the Federal Institute for Drugs and Medical Devices. But the journey did not stop there. Last week Kranus Health achieved another milestone: successful price negotiations with the GKV-Spitzenverband, which is in charge of negotiating the reimbursement amount for new medications from pharmaceutical manufacturers. Kranus Edera has now secured one of the highest permanent reimbursement prices ever recorded for a DiGA in Germany: €235 (incl. VAT). To provide some context for this exciting development we’re revisiting our episode with Jens Noertershaeuser, Founder & Co-CEO of Kranus Health. In their own words, Kranus Health’s mission is to revolutionize men's health by providing innovative and accessible healthcare solutions. As one of only 10 companies with a permanent approval, Kranus Edera is the only the first digital health app (DiGA) for the treatment of erectile dysfunction. In this episode, we cover: The background to Kranus Health The focus on men’s health and erectile dysfunction as a flagship product Products in development and the future of Kranus Health The funding journey Patient experience using the product Evidence generation and the DiGA process Insurance company reimbursment Guest Links and Resources: Connect with Jens Noertershaeuser on LinkedIn Visit kranushealth.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Meri Beckwith, Co-founder of Lindus Health. In their own words, Lindus delivers end to end clinical trials for health tech and biotech pioneers. Topics include: The background and inception story of Lindus Health Lindus Health's place in the value chain Achieving key funding milestones in a difficult market enviroment The unique aspects of clinical trials for DTx Pharmaceutical clients in the DTx market The future for clinical trials and digitization Guest Links and Resources: Connect with Meri Beckwith on LinkedIn Visit Lindus Health Episode PDF Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Susa Monacelli, General Manager at Propeller Health. In their own words Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. Topics include: The background to Propeller Health and the ResMed umbrella The original business hypothesis of ResMed and how this has evolved Patient experience using Propeller Health Differentiating propositions to health system, pharma and payers DTx vs. Disease Management 2.0 The future of prescription digital therapeutics Partnerships with health systems vs other routes to patient access Challenges holding the digital health industry back Guest Links and Resources: Connect with Susa Monacelli on LinkedIn Visit Propeller Health Episode PDF Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Have you heard? On August 22, Mahana Therapeutics announced a distribution and marketing partnership with Bayer’s consumer health division. This partnership unites Mahana’s proficiency in digital therapeutic advancement with Bayer’s commitment to empowering individuals through cutting-edge digital solutions, all aimed at enabling greater personal health control. The full press release is linked below. In light of this, we’re bringing you this replay episode with Simon Levy, CEO and Co-founder, and Ann Montgomery, Chief Product Officer at Mahana. In their own words, Mahana develops digital treatments for people living with chronic health conditions, and their first treatment, Mahana for IBS, is now available as an FDA-cleared app. In this episode, we cover: The founding story and funding journey of Mahana Complexities of the end to end patient experience The freemium model and how that translates into a PDT Evidence generation and FDA clearance process Scaling plans for PDTs Guest Links and Resources: Press Release about the Mahana and Bayer partnership Connect with Simon Levy on LinkedIn Connect with Ann Montgomery on LinkedIn Visit Mahana.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health | Orion Pharma Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Brian Wallace, CMO and Co-Founder of Calmsie. Calmsie in their own words are empowering children to develop emotional resilience from an early age. Calmsie creates engaging DTx video games designed to improve outcomes for children with depression and anxiety. In this episode, we cover: Translating addiction science to treat depression and anxiety in children The origin story and funding journey to Calmsie Parent and child experiences using the gamified program Emotional resilience training for prevention of mental health issues How the Calmsie video game affects the brain Evidence generation and deciding on PDT vs non-PDT routes The free workbook helping children understand the war in Ukraine Guest Links and Resources: Connect with Brian Wallace on LinkedIn Visit calmsie.ai YourCoach Health: Deep Dive Into Adolescent Health Episode PDF Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this special feed drop hear the first episode of Emerging Medtech Today, hosted by Henry Peck and powered by LSI. The Emerging Medtech Today podcast offers a unique opportunity to gain valuable insights from industry leaders who are building breakthrough businesses that are moving medtech forward. Join Henry as he engages in captivating conversations with innovators and investors who are at the forefront of medtech. Discover the strategies, technologies, and ideas that are shaping the future of healthcare.  In this episode Henry Peck speaks with Diana Saraceni and Alessio Beverina, co-founders and managing directors of Panakes, a venture capital firm that’s helping to build the next generation of game-changing technologies companies in the field of Life Sciences. Diana brings 23 years of venture capital experience and previously co-founded another successful venture capital firm called 360 Capital. Alessio, with an engineering background, co-founded Panakes in 2015 after working as a research engineer at Sofinnova Partners. Throughout the episode, Diana and Alessio provide valuable insights into the evolving landscape of medtech investing, shedding light on the complexities, challenges, and opportunities in the field. Topics include: Current market conditions and challenges faced by companies in medtech Key learnings from Panakes’ first fund which focused on medtech and raised €75 million Strategies for the newly raised second fund, with plans to expand its focus to include biotech and opportunities where medtech and biotech converge The impact of regulatory changes, particularly the MDR (Medical Device Regulation) shift and the increasing prioritization of FDA approval in Europe   Navigating the evolving landscape of digital health and its intersection with artificial intelligence (AI) Health tech and digital health opportunities in Europe compared to the US A reflection on the future of healthcare innovation Diana and Alessio’s upcoming participation at the LSI Europe ‘23 conference in September, where they will discuss these topics in greater detail And more! Transcript of episode Guest links and resources: Connect with Diana Saraceni: LinkedIn Connect with Alessio Beverina: LinkedIn | Twitter Panakes Connect with Henry: Twitter | LinkedIn Learn more about LSI Sign up for LSI Europe '23 Connect with LSI: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect with Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram